160 related articles for article (PubMed ID: 17979807)
1. Michael acceptors as cysteine protease inhibitors.
Santos MM; Moreira R
Mini Rev Med Chem; 2007 Oct; 7(10):1040-50. PubMed ID: 17979807
[TBL] [Abstract][Full Text] [Related]
2. Aza-peptide Michael acceptors: a new class of inhibitors specific for caspases and other clan CD cysteine proteases.
Ekici OD; Götz MG; James KE; Li ZZ; Rukamp BJ; Asgian JL; Caffrey CR; Hansell E; Dvorák J; McKerrow JH; Potempa J; Travis J; Mikolajczyk J; Salvesen GS; Powers JC
J Med Chem; 2004 Apr; 47(8):1889-92. PubMed ID: 15055989
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication.
Kong JS; Venkatraman S; Furness K; Nimkar S; Shepherd TA; Wang QM; Aubé J; Hanzlik RP
J Med Chem; 1998 Jul; 41(14):2579-87. PubMed ID: 9651162
[TBL] [Abstract][Full Text] [Related]
4. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements.
Dragovich PS; Prins TJ; Zhou R; Webber SE; Marakovits JT; Fuhrman SA; Patick AK; Matthews DA; Lee CA; Ford CE; Burke BJ; Rejto PA; Hendrickson TF; Tuntland T; Brown EL; Meador JW; Ferre RA; Harr JE; Kosa MB; Worland ST
J Med Chem; 1999 Apr; 42(7):1213-24. PubMed ID: 10197965
[TBL] [Abstract][Full Text] [Related]
5. Development of peptidomimetics with a vinyl sulfone warhead as irreversible falcipain-2 inhibitors.
Ettari R; Nizi E; Di Francesco ME; Dude MA; Pradel G; Vicík R; Schirmeister T; Micale N; Grasso S; Zappalà M
J Med Chem; 2008 Feb; 51(4):988-96. PubMed ID: 18232656
[TBL] [Abstract][Full Text] [Related]
6. Serum albumin as a probe for testing the selectivity of irreversible cysteine protease inhibitors: The case of vinyl sulfones.
Regazzoni L; Colombo S; Mazzolari A; Vistoli G; Carini M
J Pharm Biomed Anal; 2016 May; 124():294-302. PubMed ID: 26970985
[TBL] [Abstract][Full Text] [Related]
7. The Bsmoc group as a novel scaffold for the design of irreversible inhibitors of cysteine proteases.
Iley J; Moreira R; Martins L; Guedes RC; Soares CM
Bioorg Med Chem Lett; 2006 May; 16(10):2738-41. PubMed ID: 16503139
[TBL] [Abstract][Full Text] [Related]
8. Vinyl sulfones as mechanism-based cysteine protease inhibitors.
Palmer JT; Rasnick D; Klaus JL; Brömme D
J Med Chem; 1995 Aug; 38(17):3193-6. PubMed ID: 7650671
[No Abstract] [Full Text] [Related]
9. Structural basis for the inhibition of the SARS-CoV-2 main protease by the anti-HCV drug narlaprevir.
Bai Y; Ye F; Feng Y; Liao H; Song H; Qi J; Gao GF; Tan W; Fu L; Shi Y
Signal Transduct Target Ther; 2021 Feb; 6(1):51. PubMed ID: 33542181
[No Abstract] [Full Text] [Related]
10. Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors.
Scheidt KA; Roush WR; McKerrow JH; Selzer PM; Hansell E; Rosenthal PJ
Bioorg Med Chem; 1998 Dec; 6(12):2477-94. PubMed ID: 9925304
[TBL] [Abstract][Full Text] [Related]
11. The design and synthesis of inhibitors of the cysteinyl protease, Der p I.
Billson J; Clark J; Conway SP; Hart T; Johnson T; Langston SP; Ramjee M; Quibell M; Scott RK
Bioorg Med Chem Lett; 1998 May; 8(9):993-8. PubMed ID: 9871695
[TBL] [Abstract][Full Text] [Related]
12. Optimization of peptidyl allyl sulfones as clan CA cysteine protease inhibitors.
Fennell BD; Warren JM; Chung KK; Main HL; Arend AB; Tochowicz A; Götz MG
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):468-78. PubMed ID: 22380780
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of inhibition of cysteine proteases by E-64 and its derivatives.
Matsumoto K; Mizoue K; Kitamura K; Tse WC; Huber CP; Ishida T
Biopolymers; 1999; 51(1):99-107. PubMed ID: 10380357
[TBL] [Abstract][Full Text] [Related]
14. Aspartic vinyl sulfones: inhibitors of a caspase-3-dependent pathway.
Glória PM; Coutinho I; Gonçalves LM; Baptista C; Soares J; Newton AS; Moreira R; Saraiva L; Santos MM
Eur J Med Chem; 2011 Jun; 46(6):2141-6. PubMed ID: 21439692
[TBL] [Abstract][Full Text] [Related]
15. A fragment-based method to discover irreversible covalent inhibitors of cysteine proteases.
Kathman SG; Xu Z; Statsyuk AV
J Med Chem; 2014 Jun; 57(11):4969-74. PubMed ID: 24870364
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of peptidyl-vinylaminophosphonates as novel cysteine protease inhibitors.
Bhattacharya AK; Rana KC
Bioorg Med Chem; 2011 Dec; 19(23):7129-35. PubMed ID: 22019466
[TBL] [Abstract][Full Text] [Related]
17. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
Schirmeister T
J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
[TBL] [Abstract][Full Text] [Related]
18. Peptidomimetics containing a vinyl ketone warhead as falcipain-2 inhibitors.
Ettari R; Zappalà M; Micale N; Grazioso G; Giofrè S; Schirmeister T; Grasso S
Eur J Med Chem; 2011 Jun; 46(6):2058-65. PubMed ID: 21420760
[TBL] [Abstract][Full Text] [Related]
19. Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools.
Greenbaum D; Medzihradszky KF; Burlingame A; Bogyo M
Chem Biol; 2000 Aug; 7(8):569-81. PubMed ID: 11048948
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Structure-Activity Relationship Study of Epoxysuccinyl-Peptide Derivatives as Cathepsin B Inhibitors.
Zhang X; Yang X; Wang H; Li S; Guo K; Jiang D; Xiao J; Liang D
Biol Pharm Bull; 2017 Aug; 40(8):1240-1246. PubMed ID: 28502922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
